NCT05274893View on ClinicalTrials.gov

A Pharmacokinetic Comparison Study of SYHX2011 and Abraxane® in Patients With Advanced Breast Cancer

PHASE1UnknownINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 31, 2022

Primary Completion Date

September 30, 2022

Study Completion Date

October 30, 2022

Conditions
Advanced Breast Cancer
Interventions
DRUG

SYHX2011 and Abraxane®

IV infusion, 260 mg/m\^2

Sponsors
All Listed Sponsors
lead

CSPC Ouyi Pharmaceutical Co., Ltd.

INDUSTRY

NCT05274893 - A Pharmacokinetic Comparison Study of SYHX2011 and Abraxane® in Patients With Advanced Breast Cancer | Biotech Hunter | Biotech Hunter